Cargando…
Higher serum level of Cystatin C: An additional risk factor of CAD
Cystatin C has been proposed as a useful biomarker of early impaired kidney function and a predictor of mortality risk. The present study is to investigate the association between serum Cystatin C and the severity of coronary artery lesions, Gensini score (GS), and the risk of coronary artery diseas...
Autores principales: | Chen, Zhenfei, Zhang, Jing, Feng, Jun, Zhou, Gaoliang, Jin, Xiaoqin, Pan, Jianyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808466/ https://www.ncbi.nlm.nih.gov/pubmed/33466214 http://dx.doi.org/10.1097/MD.0000000000024269 |
Ejemplares similares
-
Role of serum cystatin C in the prediction of acute kidney injury following pediatric cardiac surgeries: A single center experience
por: Zakaria, Marwa, et al.
Publicado: (2022) -
Association of cystatin C with coronary artery calcification in patients undergoing multidetector computed tomography
por: Xiong, Hui, et al.
Publicado: (2021) -
Relationship of SELE A561C and G98T Variants With the Susceptibility to CAD
por: Liao, Bihong, et al.
Publicado: (2016) -
Cystatin C-based CKD-EPI estimated glomerular filtration rate equations as a better strategy for mortality stratification in acute heart failure: A STROBE-compliant prospective observational study
por: Cheang, Iokfai, et al.
Publicado: (2020) -
Retrospective cause analysis of troponin I elevation in non-CAD patients: Special emphasis on sepsis
por: Yang, Chien-Wen, et al.
Publicado: (2017)